RenovoRx (RNXT) Debt Ratio (2020)
RenovoRx's (RNXT) quarterly Debt Ratio came in at 1.38 in Q4 2020.
Powered by 
Analysis
RenovoRx (RNXT) Debt Ratio (2020) Analysis & Trends
RenovoRx has disclosed Debt Ratio across 1 years of filings, most recently posting 1.38 for Q4 2020.
- In Q4 2020, Debt Ratio changed N/A year-over-year to 1.38; the TTM figure through Dec 2020 stood at 1.38 (changed N/A YoY), while the FY2020 annual figure was 1.38, changed N/A from the prior year.
- Debt Ratio came in at 1.38 for Q4 2020 at RenovoRx.
- In the past five years, Debt Ratio ranged from a high of 1.38 in Q4 2020 to a low of 1.38 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.77 Bn | 175.17 Bn | 7.27 Bn | 0.30 |
| 2 | Intuitive Surgical | 127.65 Bn | 122.43 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn | 0.30 |
| 4 | Stryker | 104.21 Bn | 100.73 Bn | 4.50 Bn | 0.31 |
| 5 | Boston Scientific | 63.46 Bn | 62.92 Bn | 3.85 Bn | 0.28 |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.48 Bn | 1.35 Bn | 0.04 |
| 7 | Alcon | 33.01 Bn | 31.56 Bn | 1.68 Bn | 0.13 |
| 8 | Dexcom | 32.17 Bn | 30.22 Bn | 830.00 Mn | - |
| 9 | Steris | 20.72 Bn | 20.24 Bn | 684.20 Mn | 0.20 |
| 10 | RenovoRx | 84.43 Mn | 84.43 Mn | 766,000.00 | - |